Shots:
- The US FDA has granted 510(k) clearance to BlueOcean Global’s Excelsior External Fixation System, a circular external fixation platform designed to support both bone reconstruction and soft tissue management
- The system is cleared for commercial distribution in the US and will be rolled out initially through select centers, with broader availability planned in the coming months
- Excelsior integrates skeletal stabilization and soft tissue support within a single modular system and is guided by the FASTR (Fixator Assisted Soft Tissue Repair) framework, enabling coordinated management during complex limb reconstruction
Ref: GlobeNewsWire| Image: BlueOcean Global| Press Release
Related News: Abbott Secures European CE Mark for TactiFlex Duo Ablation Catheter to Treat Atrial Fibrillation
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
